Endogenous Inhibitors of Monoamine Oxidase Present in Human Cerebrospinal Fluid
- 29 July 1983
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 221 (4609), 476-478
- https://doi.org/10.1126/science.6867724
Abstract
Inhibitory activity against the enzyme monoamine oxidase is present in low molecular weight fractions (less than 100,000) of human cerebrospinal fluid. These endogenous substances of different molecular weights (3000 to more than 35,000) act like monoamine oxidase inhibitor drugs to inhibit both type A and type B monoamine oxidase.This publication has 24 references indexed in Scilit:
- Modulators of monoamine oxidase in plasmaLife Sciences, 1981
- Monoamine Oxidase in Schizophrenia: An OverviewSchizophrenia Bulletin, 1980
- Activities of Types A and B MAO and Catechol-O-methyltransferase in Blood Cells and Skin Fibroblasts of Normal and Chronic Schizophrenic SubjectsArchives of General Psychiatry, 1978
- Clinical Pharmacology of PhenelzineArchives of General Psychiatry, 1978
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- The Biochemical High-Risk Paradigm: Behavioral and Familial Correlates of Low Platelet Monoamine Oxidase ActivityScience, 1976
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitorsBritish Journal of Pharmacology, 1972
- Reduced Monoamine Oxidase Activity in Blood Platelets from Schizophrenic PatientsNature, 1972
- Biogenic Amines and EmotionScience, 1967